Disease diversity and FLT3 mutations

被引：5
|
作者：
Smith, Catherine Choy [1 ]
机构：
[1] Univ Calif San Francisco, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA
来源：
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | 2013年 / 110卷 / 52期
关键词：
ACUTE MYELOID-LEUKEMIA; INTERNAL TANDEM DUPLICATION; GASTROINTESTINAL STROMAL TUMORS; KINASE DOMAIN MUTATIONS; THERAPEUTIC TARGET; ITD MUTATIONS; RESISTANCE; VALIDATION; ACTIVATION; GEFITINIB;
D O I：
10.1073/pnas.1320579110
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：20860 / 20861
页数：2
相关论文
共 50 条
  • [31] Revisiting the prognostic role of FLT3 mutations in acute myelogenous leukemia
    Reikvam, Hakon
    EXPERT REVIEW OF HEMATOLOGY, 2023, 16 (05) : 317 - 323
  • [32] Targeting FLT3 mutations in AML: review of current knowledge and evidence
    Daver, Naval
    Schlenk, Richard F.
    Russell, Nigel H.
    Levis, Mark J.
    LEUKEMIA, 2019, 33 (02) : 299 - 312
  • [33] A new FLT3 inhibitor with two cases: the gilteritinib experience
    Serin, Istemi
    Dogu, Mehmet Hilmi
    Huq, Gulben Erdem
    Yokus, Osman
    AMERICAN JOURNAL OF BLOOD RESEARCH, 2021, 11 (03): : 271 - 278
  • [34] PMc plus cooperates with Flt3/ITD mutations to cause acute leukemia recapitulating human disease
    Rau, Rachel
    Magoon, Daniel
    Greenblatt, Sarah
    Li, Li
    Annesley, Colleen
    Duffield, Amy S.
    Huso, David
    McIntyre, Emily
    Clohessy, John G.
    Reschke, Markus
    Pandolfi, Pier Paolo
    Small, Donald
    Brown, Patrick
    EXPERIMENTAL HEMATOLOGY, 2014, 42 (02) : 101 - 113
  • [35] Discovery and Characterization of Novel Mutant FLT3 Kinase Inhibitors
    Weisberg, Ellen
    Choi, Hwan Geun
    Barrett, Rosemary
    Zhou, Wenjun
    Zhang, Jianming
    Ray, Arghya
    Nelson, Erik A.
    Jiang, Jingrui
    Moreno, Daisy
    Stone, Richard
    Galinsky, Ilene
    Fox, Edward
    Adamia, Sophia
    Kung, Andrew L.
    Gray, Nathanael S.
    Griffin, James D.
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (09) : 2468 - 2477
  • [36] FLT3 INHIBITORS: RECENT ADVANCES AND PROBLEMS FOR CLINICAL APPLICATION
    Kiyoi, Hitoshi
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2015, 77 (1-2): : 7 - 17
  • [37] Targeting FLT3 Mutations in Acute Myeloid Leukemia
    El Fakih, Riad
    Rasheed, Walid
    Hawsawi, Yousef
    Alsermani, Maamoun
    Hassanein, Mona
    CELLS, 2018, 7 (01)
  • [38] FLT3 Inhibitors in Mutant FLT3 AML
    Stone, Richard M.
    Garcia, Jacqueline
    ANNALS OF HEMATOLOGY, 2017, 96 : S36 - S37
  • [39] Effect of FLT3 Ligand on Survival and Disease Phenotype in Murine Models Harboring a FLT3 Internal Tandem Duplication Mutation
    Bailey, Emily J.
    Duffield, Amy S.
    Greenblatt, Sarah M.
    Aplan, Peter D.
    Small, Donald
    COMPARATIVE MEDICINE, 2013, 63 (03) : 218 - 226
  • [40] Acute Myeloid Leukemia Associated With Near-Tetraploid Karyotype and Mutations in the FLT3 Gene
    Jurisic, Vladimir
    Pavlovic, Sonja
    Colovic, Natasa
    Djordjevic, Vesna
    Jankovic, Gradimir
    Colovic, Milica
    LABMEDICINE, 2011, 42 (09): : 540 - 543
12345